Pacific Biosciences Of California reported $721.1M in Assets for its fiscal quarter ending in September of 2026.





Assets Change Date
Agilent USD 13.97B 902M Jun/2026
Bruker USD 5.83B 224.6M Sep/2026
Danaher USD 93.28B 914M Sep/2026
General Electric Aerospace USD 127.2B 477M Sep/2026
Illumina USD 6.81B 162M Sep/2026
Myriad Genetics USD 638.9M 34.8M Jun/2026
Pacific Biosciences Of California USD 721.1M 30.75M Sep/2026
Quidel USD 5.78B 66M Sep/2026
Revvity USD 11.49B 555.49M Sep/2026
Roche Holding CHF 98.2B 2.5B Jun/2026
Standard Biotools USD 635.33M 8.11M Sep/2026
Thermo Fisher Scientific USD 114.23B 1.06B Sep/2026
Waters USD 24.12B 636M Sep/2026